TrialHuman vaccines & immunotherapeutics2017

Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial.

Ashwani Sood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.